Bacillus Calmette–Guerin Immunotherapy for Urothelial Carcinoma of the Bladder

Immunotherapy - United Kingdom
doi 10.2217/1750743x.1.2.281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Role of IL-10 in Urinary Bladder Carcinoma and Bacillus Calmette-Guerin Immunotherapy

American Journal of Immunology
AllergyImmunology
2012English

Intravesical Bacillus Calmette-Guerin Instillation Therapy for Superficial Bladder Cancers

Japanese Journal of Urology
Urology
1990English

Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2017English

Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Efficacy and Effectiveness of Vaccination With Bacillus Calmette-Guerin

Juntendo Medical Journal
2001English

Disseminated Granulomatous Disease From Intravesical Instillation of Bacillus Calmette-Guerin

Case Reports in Oncological Medicine
Oncology
2018English

Systemic Bacillus Calmette-Guerin (BCG) Activates Natural Suppressor Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1978English

Comparison of Intravesical Bacillus Calmette‑Guerin and Mitomycin C Administration for Non‑muscle Invasive Bladder Cancer: A Meta‑analysis and Systematic Review

Oncology Letters
Cancer ResearchOncology
2016English

Re: Side Effects of Bacillus Calmette-Guerin (BCG) in the Treatment of Intermediate- And High-Risk Ta, T1 Papillary Carcinoma ...

Journal of Urological Surgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy